Heckbert SR, Li G, Cummings SR, Smith NL, Psaty BM. Use of alendronate and risk of incident atrial fibrillation in women. Arch Intern Med 2008;168:826-831. Data from the Group Health Atrial ...

A recent review of alendronate for the treatment of glucocorticoid-induced osteoporosis (GIO) found that it significantly increased bone mineral density of the lumbar spine and femoral neck in ...

Alendronate is frequently used to treat postmenopausal osteoporosis; however, the effects of long-term treatment on BMD, bone turnover, and fracture risk remain poorly characterized. The Fracture ...

Radius Health announced new data from the ACTIVExtend study evaluating fracture risk reductions in postmenopausal women receiving Tymlos (abaloparatide) injection. The full findings were presented at ...

Please provide your email address to receive an email when new articles are posted on . “Glucocorticoids are the mainstay of treatment of autoimmune inflammatory diseases, but it is also the leading ...

Compared with alendronate, teriparatide was associated with significantly greater pain reduction and better quality of life among postmenopausal women with osteoporosis. Teriparatide has a favorable ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Alendronate, a drug commonly used to treat osteoporosis, ...

If alendronate 35 mg weekly is prescribed to maintain bone density, clinicians should also recommend supplemental calcium intake, such as 1,000–1,500 mg per day, and maintain serum vitamin 25OHD ...

Romosozumab plus alendronate vs alendronate alone was associated with improved lumbar spine BMD among postmenopausal women with T2D and osteoporosis. Romosozumab followed by alendronate treatment ...

Statin pills for patient with high cholesterol Decrease in bone mass is common in the first 6 to 12 months after kidney transplantation. Long-term use of alendronate, a bisphosphonate, may slow bone ...

ARCH (Active-contRolled FraCture Study in Postmenopausal Women with Osteoporosis at High Risk of Fracture) was a multicenter, international, randomized, double-blind, alendronate-controlled study (n=4 ...

Alendronate (Ostogee -70) is used to treat or prevent osteoporosis or bone thinning in men and post-menopausal women and Paget's disease or bone deformity. It is also recommended for patients taking ...